Intravascular Imaging-Guided Versus Angiography-Guided Percutaneous Coronary Intervention : A Systematic Review and Meta-Analysis of Randomized Trials
BACKGROUND: Despite the initial evidence supporting the utility of intravascular imaging to guide percutaneous coronary intervention (PCI), adoption remains low. Recent new trial data have become available. An updated study-level meta-analysis comparing intravascular imaging to angiography to guide PCI was performed. This study aimed to evaluate the clinical outcomes of intravascular imaging-guided PCI compared with angiography-guided PCI.
METHODS AND RESULTS: A random-effects meta-analysis was performed on the basis of the intention-to-treat principle. The primary outcomes were major adverse cardiac events, cardiac death, and all-cause death. Mixed-effects meta-regression was performed to investigate the impact of complex PCI on the primary outcomes. A total of 16 trials with 7814 patients were included. The weighted mean follow-up duration was 28.8 months. Intravascular imaging led to a lower risk of major adverse cardiac events (relative risk [RR], 0.67 [95% CI, 0.55-0.82]; P<0.001), cardiac death (RR, 0.49 [95% CI, 0.34-0.71]; P<0.001), stent thrombosis (RR, 0.63 [95% CI, 0.40-0.99]; P=0.046), target-lesion revascularization (RR, 0.67 [95% CI, 0.49-0.91]; P=0.01), and target-vessel revascularization (RR, 0.60 [95% CI, 0.45-0.80]; P<0.001). In complex lesion subsets, the point estimate for imaging-guided PCI compared with angiography-guided PCI for all-cause death was a RR of 0.75 (95% CI, 0.55-1.02; P=0.07).
CONCLUSIONS: In patients undergoing PCI, intravascular imaging is associated with reductions in major adverse cardiac events, cardiac death, stent thrombosis, target-lesion revascularization, and target-vessel revascularization. The magnitude of benefit is large and consistent across all included studies. There may also be benefits in all-cause death, particularly in complex lesion subsets. These results support the use of intravascular imaging as standard of care and updates of clinical guidelines.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:13 |
|---|---|
| Enthalten in: |
Journal of the American Heart Association - 13(2024), 2 vom: 16. Jan., Seite e031111 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Sreenivasan, Jayakumar [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Intravascular ultrasound |
|---|
| Anmerkungen: |
Date Completed 17.01.2024 Date Revised 13.03.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1161/JAHA.123.031111 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM367048183 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM367048183 | ||
| 003 | DE-627 | ||
| 005 | 20240313234045.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240114s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1161/JAHA.123.031111 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1326.xml |
| 035 | |a (DE-627)NLM367048183 | ||
| 035 | |a (NLM)38214263 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Sreenivasan, Jayakumar |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Intravascular Imaging-Guided Versus Angiography-Guided Percutaneous Coronary Intervention |b A Systematic Review and Meta-Analysis of Randomized Trials |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 17.01.2024 | ||
| 500 | |a Date Revised 13.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a BACKGROUND: Despite the initial evidence supporting the utility of intravascular imaging to guide percutaneous coronary intervention (PCI), adoption remains low. Recent new trial data have become available. An updated study-level meta-analysis comparing intravascular imaging to angiography to guide PCI was performed. This study aimed to evaluate the clinical outcomes of intravascular imaging-guided PCI compared with angiography-guided PCI | ||
| 520 | |a METHODS AND RESULTS: A random-effects meta-analysis was performed on the basis of the intention-to-treat principle. The primary outcomes were major adverse cardiac events, cardiac death, and all-cause death. Mixed-effects meta-regression was performed to investigate the impact of complex PCI on the primary outcomes. A total of 16 trials with 7814 patients were included. The weighted mean follow-up duration was 28.8 months. Intravascular imaging led to a lower risk of major adverse cardiac events (relative risk [RR], 0.67 [95% CI, 0.55-0.82]; P<0.001), cardiac death (RR, 0.49 [95% CI, 0.34-0.71]; P<0.001), stent thrombosis (RR, 0.63 [95% CI, 0.40-0.99]; P=0.046), target-lesion revascularization (RR, 0.67 [95% CI, 0.49-0.91]; P=0.01), and target-vessel revascularization (RR, 0.60 [95% CI, 0.45-0.80]; P<0.001). In complex lesion subsets, the point estimate for imaging-guided PCI compared with angiography-guided PCI for all-cause death was a RR of 0.75 (95% CI, 0.55-1.02; P=0.07) | ||
| 520 | |a CONCLUSIONS: In patients undergoing PCI, intravascular imaging is associated with reductions in major adverse cardiac events, cardiac death, stent thrombosis, target-lesion revascularization, and target-vessel revascularization. The magnitude of benefit is large and consistent across all included studies. There may also be benefits in all-cause death, particularly in complex lesion subsets. These results support the use of intravascular imaging as standard of care and updates of clinical guidelines | ||
| 650 | 4 | |a Meta-Analysis | |
| 650 | 4 | |a Systematic Review | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a intravascular ultrasound | |
| 650 | 4 | |a meta‐analysis | |
| 650 | 4 | |a optical coherence tomography | |
| 650 | 4 | |a percutaneous coronary intervention | |
| 700 | 1 | |a Reddy, Rohin K |e verfasserin |4 aut | |
| 700 | 1 | |a Jamil, Yasser |e verfasserin |4 aut | |
| 700 | 1 | |a Malik, Aaqib |e verfasserin |4 aut | |
| 700 | 1 | |a Chamie, Daniel |e verfasserin |4 aut | |
| 700 | 1 | |a Howard, James P |e verfasserin |4 aut | |
| 700 | 1 | |a Nanna, Michael G |e verfasserin |4 aut | |
| 700 | 1 | |a Mintz, Gary S |e verfasserin |4 aut | |
| 700 | 1 | |a Maehara, Akiko |e verfasserin |4 aut | |
| 700 | 1 | |a Ali, Ziad A |e verfasserin |4 aut | |
| 700 | 1 | |a Moses, Jeffrey W |e verfasserin |4 aut | |
| 700 | 1 | |a Chen, Shao-Liang |e verfasserin |4 aut | |
| 700 | 1 | |a Chieffo, Alaide |e verfasserin |4 aut | |
| 700 | 1 | |a Colombo, Antonio |e verfasserin |4 aut | |
| 700 | 1 | |a Leon, Martin B |e verfasserin |4 aut | |
| 700 | 1 | |a Lansky, Alexandra J |e verfasserin |4 aut | |
| 700 | 1 | |a Ahmad, Yousif |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of the American Heart Association |d 2012 |g 13(2024), 2 vom: 16. Jan., Seite e031111 |w (DE-627)NLM222412712 |x 2047-9980 |7 nnns |
| 773 | 1 | 8 | |g volume:13 |g year:2024 |g number:2 |g day:16 |g month:01 |g pages:e031111 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1161/JAHA.123.031111 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 13 |j 2024 |e 2 |b 16 |c 01 |h e031111 | ||